Article
[What's new in dermato-oncology?].
Annales de dermatologie et de venereologie - 1 Dec 2011
Basset-Séguin N
Abstract excerpt
One of the major advance concerning skin carcinoma is the development of targeted therapy: anti-patch/sonic/hedgehog for basal cell carcinoma (BCC) and anti-EGFR for squamous cell carcinoma (SCC). These therapies are indicated for advanced non surgically removable tumors. Their anti-tumoral efficacy has been shown, their effect seems to be suspensive which raises the question of their tolerability for long term...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
